Sironax
Waltham, US · 4 known investors
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases. Its research targets conditions affecting longevity, those requiring supportive care, and certain rare diseases.
BiotechHealthtechLongevity
Investors · 4
Competitors · 4
by search overlapSionnatx24 shared keywordsSionna Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule medicines for cystic fibrosis by stabilizing the CFTR protein's NBD1 domain to correct defects from the F508del mutation. It is also building a portfolio of complementary CFTR modulators intended to work with its NBD1 stabilizers to restore CFTR function in CF patients.
Bioworld22 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Sirnaomics18 shared keywordsSirnaomics is an RNA therapeutics company developing RNA interference (RNAi) drugs using its proprietary PNP (Peptide Nanoparticle) delivery platform for extra-hepatic delivery and its GalAHead technology for controlling therapeutic duration. Its pipeline spans oncology, regenerative and aesthetic medicine, and cardiovascular and metabolic diseases.
Day One Biopharmaceuticals17 shared keywordsDay One Biopharmaceuticals is an oncology drug developer that pursues a "search and development" strategy to bring targeted cancer medicines to patients of all ages, with a focus on pediatric low-grade glioma (pLGG). The company is part of Servier.
Companies competing with Sironax for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sironax do?
- Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases. Its research targets conditions affecting longevity, those requiring supportive care, and certain rare diseases.
- Who are Sironax's investors?
- Sironax's investors include ARCH Venture Partners, F-Prime Capital Partners, YuanBio Venture Capital, Future Innovation.
- Where is Sironax headquartered?
- Sironax is headquartered in Waltham, US.